← FDA Drug Approvals (Drugs@FDA)

METRONIDAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2022-01-27

Drug application

FDA Application #
ANDA215794
Application type
Abbreviated New Drug Application (Generic)
Brand name
METRONIDAZOLE
Generic name
METRONIDAZOLE
Active ingredients
METRONIDAZOLE
Dosage form
GEL
Route
VAGINAL
Marketing status
Prescription
Sponsor
GLENMARK PHARMS LTD
Manufacturer
Northstar Rx LLC
First approval
2022-01-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown